Skip to main content
U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute announces the availability of funding for implementation of the Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Exploratory/Developmental Research Grant. The purpose of this grant is to encourage integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies. The R21 exploratory/developmental grant supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant . . .
Content Restricted

This article is reserved for members with an active Premium Membership. Please purchase a Premium Membership to view this resource.

Purchase A Premium Account

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!

Close

Support Request

Need help now?

Call our toll-free phone number 877-350-6463